Roux-en-Y versus one-anastomosis gastric bypass (RYSA study): weight loss, metabolic improvements, and nutrition at 1 year after surgery, a multicenter randomized controlled trial.
Sini HeinonenTuure SaarinenSanna MeriläinenHenna SammalkorpiAnne K PenttiläMinna KoivikkoPertti SiiraJaro KarppinenUlla SäiläkiviMilla Rosengård-BärlundVesa KoivukangasKirsi H PietiläinenAnne JuutiPublished in: Obesity (Silver Spring, Md.) (2023)
RYGB and OAGB were comparable in weight loss, metabolic improvement, remission of diabetes and hypercholesterolemia, and nutrition at 1-year follow-up. Vitamin D-25 deficiency was more prevalent with OAGB, whereas reduction in antihypertensive medications and hypertension was greater with RYGB. There is no need to change the current practices of RYGB in favor of OAGB.
Keyphrases
- roux en y gastric bypass
- gastric bypass
- weight loss
- bariatric surgery
- randomized controlled trial
- blood pressure
- glycemic control
- obese patients
- physical activity
- type diabetes
- primary care
- healthcare
- study protocol
- cardiovascular disease
- weight gain
- cardiovascular events
- clinical trial
- double blind
- hypertensive patients
- metabolic syndrome
- adipose tissue
- disease activity
- systemic lupus erythematosus
- ulcerative colitis
- arterial hypertension